Iofina Regulatory News (IOF)

15 February 2016

Iofina Plc

("Iofina" or "the Company")

(LSE AIM: IOF)

DIRECTORATE CHANGE

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, today announces the resignation of Neil Hekking as Executive Director and Chief Financial Officer ("CFO") with immediate effect. Neil's resignation is due to family health and relocation issues and the Board extends its very best wishes.

Mr. Malcolm Lewin, who has worked with Iofina on previous finance-related and AIM projects and is based out of the UK, has been appointed as Interim CFO and a non-Board position, to ensure continuity. The Board expects to provide a further update regarding an on-going Board appointment in due course.

Malcolm joins with over 30 years' experience in finance and accounting at both public and private companies. As well as being a partner in a chartered accounting firm for 11 years, he has acted in senior roles for various companies that are or have been listed on AIM, TSX-V and NYSE-MKT global stock exchanges. Mr Lewin has an MA in Classics from Oxford University and qualified as a chartered accountant with Coopers & Lybrand.

Commenting, President and CEO Dr. Tom Becker, stated: "The Board wishes Neil and his family the very best at what is a difficult time. We welcome Malcolm back to Iofina and look forward to working with him again."

Outgoing CFO, Neil Hekking, added: " With regret I must step down as CFO of Iofina to focus on family matters. I am appreciative of having been part of the Iofina family and I wish the team much success for the future."

Enquiries:

For further information, please contact:

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

Christopher Raggett/Giles Rolls/Joanna Scott

finnCap Ltd

Tel: +44 (0)20 7220 0500

Dominic Barretto/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com